← 홈

ADC

505개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 505개
ADCBiologicstaleNBE-Therapeutics AGPhase 2

NBE-002 (NBE-002)

Advanced Solid Tumor; Advanced Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleNovelty Nobility, Inc.Phase 1

NN3201 (NN3201)

Gastrointestinal Stromal Tumors; Small-cell Lung Cancer · Gastrointestinal Stromal Tumors

#GastrointestinalStromalTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleXijing HospitalPhase 2

Neratinib Combined with Fulvestrant and Eribulin (Neratinib Combined with Fulvestrant and Eribulin)

Brest Cancer · Brest Cancer

#BrestCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFox Chase Cancer CenterPhase 1

Neratinib Pill (Neratinib Pill)

Gastric Cancer; Gastrointestinal Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleGilead SciencesPreclinical

ADC (Non-Investigational Antibody-Drug Conjugates, Non-Investigational Antibody-Drug Conjugates (ADC))

HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleOrum Therapeutics USA, Inc.Phase 1

ORM-5029 (ORM-5029)

HER2-positive Breast Cancer; HER-2 Protein Overexpression · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleBioAtla, Inc.Phase 2

Ozuriftamab Vedotin (Ozuriftamab Vedotin)

Head and Neck Cancer; Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

#HeadandNeckCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstalePfizerPhase 1

PF-08046033 (PF-08046033)

Non-Small-Cell Lung; Esophageal Cancer · Non-Small-Cell Lung

#Non-Small-CellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstalePfizerPhase 1

PF-08046876 (PF-08046876)

Advanced/Metastatic Solid Tumors; Bladder Cancer · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 RECRUITING
ADCBiologicstalePheon TherapeuticsPhase 1

PHN-010 (PHN-010)

Lung Cancer; Colon Cancer · Lung Cancer

#LungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstalePheon TherapeuticsPhase 1

PHN-012 (PHN-012)

Colon Cancer; Pancreatic Cancer · Colon Cancer

#ColonCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleNorthwestern UniversityPhase 1

PI3K inhibitor BYL719 (PI3K inhibitor BYL719)

HER2-positive Breast Cancer; Recurrent Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 4%임상시험 1상태 ACTIVE
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

PRG2505 (PRG2505)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBorstkanker Onderzoek GroepPhase 2

PTC-Pz (PTC-Pz)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleM.D. Anderson Cancer CenterPhase 1

STI-6129 (Part 1, Part 1 (STI-6129))

Refractory T Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia (AML) · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleM.D. Anderson Cancer CenterPhase 1

STI-6129 (Part 2, Part 2 (STI-6129))

Refractory T Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia (AML) · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleShattuck Labs, Inc.Phase 1

Pegylated Liposomal Doxorubicin + SL-172154 (Pegylated Liposomal Doxorubicin + SL-172154)

Platinum-resistant Ovarian Cancer; Fallopian Tube Cancer · Platinum-resistant Ovarian Cancer

#Platinum-resistantOvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleJiangsu Alphamab Biopharmaceuti…Phase 2

Platinum (Platinum)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 4.86%임상시험 1상태 RECRUITING
ADCBiologicstaleQilu Pharmaceutical Co., Ltd.Phase 1

QLS5212 (QLS5212)

Solid Tumor Cancer · Solid Tumor Cancer

#SolidTumorCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

RC148 (RC148)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING

23 / 26 페이지

← 이전다음 →